Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.
Thompson P, Badell IR, Lowe M, Turner A, Cano J, Avila J, Azimzadeh A, Cheng X, Pierson RN 3rd, Johnson B, Robertson J, Song M, Leopardi F, Strobert E, Korbutt G, Rayat G, Rajotte R, Larsen CP, Kirk AD.
Thompson P, et al.
Am J Transplant. 2012 Jul;12(7):1765-75. doi: 10.1111/j.1600-6143.2012.04031.x. Epub 2012 Mar 28.
Am J Transplant. 2012.
PMID: 22458586
Free PMC article.